Research map: Rewiring immunometabolism in hepato-biliary-pancreatic cancers: Unraveling TME-mediated metabolic suppression and advancing next-generation immunotherapeutic approaches

Back to the article

Papers in this map

  1. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression · Chih‐Hao Chang · 2015 · 3398 citations · Cited by this paper
  2. Logic-gated nanoregulators: A paradigm shift from drug delivery to pre-programmed multi-target immunotherapy · Yimao Wu · 2026 · Cites this paper
  3. Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis · 2026 · Related
  4. CAR T cell immunotherapy for human cancer · Carl H. June · 2018 · 3261 citations · Cited by this paper
  5. Food and Medicine Homology Substances Remodel Gut Microbiota for Tumor Therapy · Yimao Wu · 2026 · Cites this paper
  6. The future of TCR-Treg therapies is renewables · 2026 · Related
  7. Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance · Hariharan Easwaran · 2014 · 951 citations · Cited by this paper
  8. Emerging therapeutic frontiers in breast cancer management: From nanotechnology and immunotherapy to targeted drug delivery and novel biomarkers · N. Vignesh · 2026 · Cites this paper
  9. Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases · 2026 · Related
  10. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity · Alison Epstein Ringel · 2020 · 807 citations · Cited by this paper
  11. Tumour Mutation Burden Does Not Predict Immune Cell Frequency or Risk of Recurrence After Surgery in Hepatocellular Carcinoma · Adam C. Connor · 2026 · Cites this paper
  12. Inflammatory biomarkers of atherosclerosis in SLE that may improve SLE-specific cardiovascular risk assessment tools · 2026 · Related
  13. Cancer stem cell definitions and terminology: the devil is in the details · Peter Valent · 2012 · 697 citations · Cited by this paper
  14. Mapping immune cell metabolic reprogramming from mechanistic hotspots to translational directions: A bibliometric analysis with exploratory clinical evidence · Linxin Liu · 2026 · Cites this paper
  15. Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions · 2026 · Related
  16. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy · Ali F. Abdel-Wahab · 2019 · 614 citations · Cited by this paper
  17. The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation · 2026 · Related
  18. Advances in the early diagnosis of hepatocellular carcinoma · Weiyi Wang · 2020 · 527 citations · Cited by this paper
  19. Fatty acid oxidation and inflammatory bowel disease: Highlighting the roles of pathogenesis and treatment · 2026 · Related
  20. Metabolism, metabolites, and macrophages in cancer · Mengyuan Li · 2023 · 513 citations · Cited by this paper
  21. Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link? · 2026 · Related
  22. Metabolic and epigenetic regulation of T-cell exhaustion · Fabien Franco · 2020 · 464 citations · Cited by this paper
  23. The role of myeloid-derived suppressor cells in Sjögren's disease · 2026 · Related
  24. Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma · Assaf Magen · 2023 · 429 citations · Cited by this paper
  25. Tumor and Systemic Immunomodulatory Effects of MEK Inhibition · 2021 · Related
  26. Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers · Hao Zhang · 2023 · 402 citations · Cited by this paper
  27. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer · Deanna N. Edwards · 2020 · 380 citations · Cited by this paper
  28. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells · Ilaria Elia · 2022 · 372 citations · Cited by this paper
  29. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy · Luming Yang · 2023 · 363 citations · Cited by this paper
  30. Current Development Status of MEK Inhibitors · Ying Cheng · 2017 · 305 citations · Cited by this paper
  31. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity · Chuansheng Guo · 2023 · 302 citations · Cited by this paper
  32. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism · Margaret M. Billingsley · 2023 · 265 citations · Cited by this paper
  33. Metabolic reprogramming in the tumor microenvironment of liver cancer · Jian Lin · 2024 · 245 citations · Cited by this paper
  34. The Warburg effect: a signature of mitochondrial overload · Yahui Wang · 2023 · 237 citations · Cited by this paper
  35. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States · Nabihah Tayob · 2022 · 229 citations · Cited by this paper
  36. ENO1 and Cancer · Chen Kai Huang · 2022 · 228 citations · Cited by this paper
  37. Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment · Ellen N. Scott · 2021 · 195 citations · Cited by this paper
  38. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer · Siva Karthik Varanasi · 2025 · 173 citations · Cited by this paper
  39. Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases · Miranda D. Chávez · 2021 · 172 citations · Cited by this paper

Source: OpenAlex (CC0)